|
|
Improved Renal Function and Modest Hemodynamic Changes With Adenosine-Receptor Antagonist
|
| Link ID |
9156 |
| Title |
Improved Renal Function and Modest Hemodynamic Changes With Adenosine-Receptor Antagonist |
| Url |
http://www.medscape.com/viewarticle/581241?src=rss |
| Description |
The agent modestly reduced pulmonary capillary wedge pressures at the highest doses, had a weak diuretic effect, and improved renal-function measures. More research into the effects of A1-receptor antagonists on morbidity and mortality are still needed, say investigators. Heartwire |
| Category |
Articles > Cardiology |
| Keywords |
|
| Date |
Sep 30, 2008 |
| Contact Name |
|
| Email |
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
|
Other links at Articles > Cardiology |
| 1. |
FDA Safety Changes: Advair HFA, Tekturna HCT, Lovenox
|
|
|
The FDA has approved revisions to the safety labeling for fluticasone propionate plus salmeterol xinafoate, aliskiren hemifumarate plus hydrochlorothiazide tablets, and enoxaparin sodium injection. Medscape Medical News
|
|
|